Trial Profile
Retrospective study of Anidulafungin in pediatric patients for invasive fungal infection, from the medical records in a pediatric hospital
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2015
Price :
$35
*
At a glance
- Drugs Anidulafungin (Primary)
- Indications Mycoses
- Focus Adverse reactions
- 21 Jan 2015 New trial record